Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Acellera
Acellera Therapeutics is a drug discovery company leveraging AI and quantum chemistry solutions for early-stage drug discovery. Their platform, QuantumBind®, focuses on small-molecule discovery and…
Acellera
Acellera Therapeutics is a drug discovery company leveraging AI and quantum chemistry solutions for early-stage drug discovery. Their platform, QuantumBind®, focuses on small-molecule discovery and…
TL;DR
What they do: Computational drug-discovery using molecular simulation, AI/ML, and quantum-informed methods
Founded: 2006 (company site) with a U.S. corporation launch in 2023
Notable products: ACEMD, AceForce, PlayMolecule suite and other ML/MD toolkits
Funding status: Reports no external investors and a simple cap table; seeking partners/funding in 2026
Company Overview
Problem Domain
Early-stage small-molecule drug discovery (molecular simulation, potency prediction, lead prioritization).
Founded
2006
Industry
Biotechnology
Tech Stack
Funding Track Record
54634
Investor Signal
“Company states it currently has no external investment and a very simple cap table; plans to seek funding/partnerships in 2026”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,300+
New This Week